"Endpoint Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.
Descriptor ID |
D023381
|
MeSH Number(s) |
E05.315
|
Concept/Terms |
Endpoint Determination- Endpoint Determination
- Determination, Endpoint
- Determinations, Endpoint
- Endpoint Determinations
- End Point Determination
- Determinations, End Point
- End Point Determinations
- Point Determinations, End
Endpoint Assay- Endpoint Assay
- Assay, Endpoint
- Assays, Endpoint
- Endpoint Assays
- End Point Assay
- Assay, End Point
- Assays, End Point
- End Point Assays
- Point Assay, End
- Point Assays, End
|
Below are MeSH descriptors whose meaning is more general than "Endpoint Determination".
Below are MeSH descriptors whose meaning is more specific than "Endpoint Determination".
This graph shows the total number of publications written about "Endpoint Determination" by people in this website by year, and whether "Endpoint Determination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 1 | 2 |
2002 | 0 | 2 | 2 |
2004 | 0 | 5 | 5 |
2005 | 0 | 10 | 10 |
2006 | 1 | 2 | 3 |
2007 | 2 | 2 | 4 |
2008 | 2 | 2 | 4 |
2009 | 1 | 3 | 4 |
2010 | 0 | 8 | 8 |
2011 | 0 | 2 | 2 |
2012 | 1 | 5 | 6 |
2013 | 0 | 5 | 5 |
2014 | 4 | 4 | 8 |
2015 | 3 | 6 | 9 |
2016 | 5 | 5 | 10 |
2017 | 4 | 4 | 8 |
2018 | 7 | 6 | 13 |
2019 | 2 | 2 | 4 |
2020 | 5 | 6 | 11 |
2021 | 1 | 2 | 3 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endpoint Determination" by people in Profiles.
-
The development of a core outcome set for clinical effectiveness studies of bordered foam dressings in the treatment of complex wounds. J Tissue Viability. 2023 Aug; 32(3):430-436.
-
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT. J Am Coll Cardiol. 2021 10 12; 78(15):1525-1537.
-
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience. Int J Cancer. 2021 07 15; 149(2):387-393.
-
Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape. Clin Trials. 2021 06; 18(3):324-334.
-
Window of Opportunity Clinical Trials to Evaluate Novel Therapies for Brain Tumors. Neurosurg Clin N Am. 2021 Jan; 32(1):93-104.
-
Increased mu-opioid receptor expression is associated with reduced disease-free and overall survival in laryngeal squamous cell carcinoma. Br J Anaesth. 2020 11; 125(5):722-729.
-
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol. 2021 01; 74(1):200-219.
-
Comparing Radiation Modalities with Trimodality Therapy Using Total Toxicity Burden. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):1001-1005.
-
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial. Respir Res. 2020 Jul 09; 21(1):177.
-
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. J Clin Oncol. 2020 09 10; 38(26):3032-3041.